Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences

About this trial

The purpose of this study is to determine the effectiveness of prophylactic administration of intra-thecal nicardipine though lumbar cerebrospinal fluid drain in prevention of symptomatic vasospasm in patients with subarachnoid hemorrhage due to rupture of cerebral aneurysms.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years

Aneurysmal subarachnoid hemorrhage with Hunt and Hess score 3 or less

Patient or legal authorized representative available to sign the informed consent form

Pre-morbid modified Rankin scale of 0 or 1.

Disqualifiers

Pregnant females

Subarachnoid hemorrhage (SAH) with hunt and hess scale of >3

SAH due to etiology other than aneurysmal rupture

Any contraindications in patients receiving calcium channel antagonists like hypersensitivity to dihydropyridines

Trial design

Design model

Parallel

Treatments tested in this trial

  • Normal Saline

    Drug

    10 mL preservative-free normal saline in luer-lock sterile syringe every 24 hours from randomization through day 14 post-bleed or lumbar drain removal, whichever occurs first.

  • Nicardipine

    Drug

    Nicardipine 4 mg will be diluted in preservative-free normal saline to 10 mL in luer-lock sterile syringe every 24 hours from randomization through day 14 post-bleed or lumbar drain removal, whichever occurs first.

Treatment groups

214 Participants
are divided into 2 treatment groups
Group A: Standard of CareSham comparator 1 intervention
Group B: Standard of Care Plus NicardipineExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of Vasospasm

The incidence of symptomatic clinical or radiographic vasospasm in patients treated with prophylactic administration of intrathecal nicardipine though lumbar drain

Time frame
up to hospitalization day 21
2

Incidence of Delayed Cerebral Ischemia

The incidence of symptomatic clinical or radiographic delayed cerebral ischemia in patients treated with prophylactic administration of intrathecal nicardipine though lumbar drain

Time frame
up to hospitalization day 21

Secondary outcomes

1

Modified Rankin Scale Score

The Modified Rankin Scale is a clinical tool used to assess the functional disability after a stroke. It is a six-point ordinal scale that measures the patient's ability to perform activities of daily living. Score Range: 0 no symptoms, 1 no significant disability, 2 slight disability, 3 moderate disability, 4 moderately severe disability, 5 severe disability, 6 dead.

Time frame
month 6
2

Incidence of Meningitis

Incidence of meningitis as confirmed by clinical and laboratory findings

Time frame
up to hospitalization day 21

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: